Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Replimune Group, Inc. | 263,736 | reported | 12 Sept 2023 | tx 84+893,142−672,783 |
| Kymera Therapeutics, Inc. | 1,000 | reported | 19 May 2026 | tx 46+176,253−119,126 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 19 May 2026 | EXERCISE | Kymera Therapeutics, Inc. | 1,000 | 31.20 USD | |
| 19 May 2026 | EXERCISE | Kymera Therapeutics, Inc. | 1,000 | 0.00 USD | deriv |
| 20 Mar 2026 | SALE | Kymera Therapeutics, Inc. | 1,200 | 79.94 USD | |
| 20 Mar 2026 | SALE | Kymera Therapeutics, Inc. | 600 | 79.24 USD | |
| 20 Mar 2026 | SALE | Kymera Therapeutics, Inc. | 700 | 77.71 USD | |
| 20 Mar 2026 | EXERCISE | Kymera Therapeutics, Inc. | 2,500 | 49.10 USD | |
| 20 Mar 2026 | EXERCISE | Kymera Therapeutics, Inc. | 2,500 | 0.00 USD | deriv |
| 20 Feb 2026 | EXERCISE | Kymera Therapeutics, Inc. | 2,500 | 49.10 USD | |
| 20 Feb 2026 | SALE | Kymera Therapeutics, Inc. | 1,900 | 87.06 USD | |
| 20 Feb 2026 | SALE | Kymera Therapeutics, Inc. | 600 | 88.10 USD | |
| 20 Feb 2026 | EXERCISE | Kymera Therapeutics, Inc. | 2,500 | 0.00 USD | deriv |
| 20 Jan 2026 | SALE | Kymera Therapeutics, Inc. | 200 | 68.52 USD | |
| 20 Jan 2026 | EXERCISE | Kymera Therapeutics, Inc. | 3,000 | 31.20 USD | |
| 20 Jan 2026 | EXERCISE | Kymera Therapeutics, Inc. | 2,500 | 49.10 USD | |
| 20 Jan 2026 | SALE | Kymera Therapeutics, Inc. | 400 | 66.68 USD | |
| 20 Jan 2026 | SALE | Kymera Therapeutics, Inc. | 4,900 | 67.99 USD | |
| 20 Jan 2026 | EXERCISE | Kymera Therapeutics, Inc. | 2,500 | 0.00 USD | deriv |
| 20 Jan 2026 | EXERCISE | Kymera Therapeutics, Inc. | 3,000 | 0.00 USD | deriv |
| 17 Dec 2025 | EXERCISE | Kymera Therapeutics, Inc. | 3,000 | 31.20 USD | |
| 17 Dec 2025 | SALE | Kymera Therapeutics, Inc. | 7,959 | 82.34 USD | |
| 17 Dec 2025 | SALE | Kymera Therapeutics, Inc. | 4,099 | 83.45 USD | |
| 17 Dec 2025 | SALE | Kymera Therapeutics, Inc. | 1,000 | 84.07 USD | |
| 17 Dec 2025 | EXERCISE | Kymera Therapeutics, Inc. | 12,000 | 27.67 USD | |
| 17 Dec 2025 | EXERCISE | Kymera Therapeutics, Inc. | 12,563 | 49.10 USD | |
| 17 Dec 2025 | SALE | Kymera Therapeutics, Inc. | 14,505 | 81.56 USD |